Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 101–150 of 4,689 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07439653	A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma	recruiting	Phase 1 / Phase 2	155	TORL Biotherapeutics, LLCINDUSTRY	1	Sep 28, 2026	clinicaltrials
NCT07519655	Phase 1 Study of PF-08046033 in Advanced Solid Tumors	recruiting	Phase 1	250	PfizerINDUSTRY	5	Sep 28, 2026	clinicaltrials
NCT07594106